BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31292111)

  • 21. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma.
    Kakkassery V; Schroers R; Coupland SE; Wunderlich MI; Schargus M; Heinz C; Wasmuth S; Heiligenhaus A; Ahle G; Lenoble P; Schlegel U; Schmiegel W; Dick HB; Baraniskin A
    Blood; 2017 Jun; 129(23):3130-3133. PubMed ID: 28389463
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
    Rajagopal R; Harbour JW
    Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
    Takhar JS; Doan TA; Gonzales JA
    Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma.
    Brown NA; Rao RC; Betz BL
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial Detection of
    Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
    Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
    Kase S; Namba K; Kanno-Okada H; Onozawa M; Hidaka D; Iwata D; Mizuuchi K; Fukuhara T; Fukuhara J; Kitaichi N; Matsuno Y; Ishida S
    Ocul Immunol Inflamm; 2020; 28(1):147-155. PubMed ID: 30335535
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of primary vitreoretinal lymphoma.
    Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
    Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
    Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
    Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
    [No Abstract]   [Full Text] [Related]  

  • 31. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
    Bonzheim I; Sander P; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Steinhilber J; Kohler E; Büssgen M; Schittenhelm J; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
    Blood Adv; 2022 Mar; 6(5):1598-1607. PubMed ID: 34448823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy.
    Cani AK; Toral MA; Balikov DA; Betz BL; Hu K; Liu CJ; Prifti MV; Chinnaiyan AM; Tomlins SA; Mahajan VB; Rao RC
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary vitreoretinal lymphoma.
    Mulay K; Narula R; Honavar SG
    Indian J Ophthalmol; 2015 Mar; 63(3):180-6. PubMed ID: 25971162
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
    Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary intraocular lymphoma in a patient with systemic lupus erythematosus.
    Woei-A-Jin FJ; Kersting S; Bollemeijer JG
    Ann Hematol; 2012 Nov; 91(11):1821-2. PubMed ID: 22552607
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic procedures in vitreoretinal lymphoma.
    Dalal M; Casady M; Moriarty E; Faia L; Nussenblatt R; Chan CC; Sen HN
    Ocul Immunol Inflamm; 2014 Aug; 22(4):270-6. PubMed ID: 24377379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of MYD88 Mutations in Vitreoretinal Lymphoma and Its Implications.
    Touitou V; Costopoulos M; Maloum K
    JAMA Ophthalmol; 2018 Oct; 136(10):1104-1105. PubMed ID: 30027276
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis.
    Tuo J; Shen D; Yang HH; Chan CC
    Am J Ophthalmol; 2014 Mar; 157(3):728-34. PubMed ID: 24345320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and therapeutic challenges.
    Jung JJ; Milman T; Chin KJ; Finger PT; Aizman A; Johnson RN
    Retina; 2013 Oct; 33(9):1983-8. PubMed ID: 23594719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.